Introduction
Intravenous feeding is recognised as valuable in patients unable to take nourishment by mouth or nasogastric tube. The feeds are usually administered via a subclavian catheter which requires skilful placement. The risks of insertion and infection of the catheter are well recognised, so some hospitals employ a peripatetic team of experts to manage their patients (Powell-Tuck et al., 1978; Fischer, 1977) .
Peripheral veins may be used for intravenous nutrition if lipid emulsions such as Intralipid (Kabi Vitrum Ltd) rather than dextrose are used as the major calorie source. This also reduces the risk of hyperglycaemia during infusion, but it has been *Present address: Oldchurch Hospital, Romford, Essex RM7 OBE. assumed that the fat emulsion must be kept separate from other infusates. The infusion of more than one bottle simultaneously or sequentially complicates nursing procedures, makes errors more likely and makes it difficult to ensure the administration of a balanced regime.
In this paper, we describe the use of an Intralipidbased intravenous feed made up in a single 3 litre bag and infused over 24 hr. The stability of the mixture as measured by physical tests has been reported elsewhere (Burnham et al., 1983) . This feed can be given through peripheral veins, and appears safe and effective in achieving positive nitrogen balance. Table 1 ; the feed was designed to meet the needs of patients with diarrhoea or fistula losses. Patients with other conditions might need less potassium. The calcium and phosphate ion concentrations were well below the point at which precipitation would be likely (Nedich, 1977) . Further unpublished work confirms that this does not occur (Davis, personal communication, 1982) .
Materials
Less nitrogen or electrolyte was given if clinically appropriate and all ingredients were mixed in a three litre bag (Travenol Laboratories Ltd.). In some instances 2000 i.u. heparin was added because it was thought possible that it might reduce the frequency of deep vein thrombosis and pulmonary embolism. (Negus et al., 1980) and increase the survival of peripheral veins (Stradling, 1978) . It might also Simpl#ied intravenous nutrition slightly improve the stability of the emulsion mixture (Kawilarang, Georghiou and Groves, 1980) . Patients studied (Table 2) These were patients with severe alimentary disease in need of intravenous nutritional support. Infusions were made through peripheral veins whenever possible. Nitrogen balance was calculated from daily blood and urinary area measurements (Lee and Hartley, 1975 ) using standard techniques. Stool losses were not measured, but only two of the patients with active inflammatory bowel disease likely to cause such significant losses (as opposed to structural disease such as obstruction) were studied before surgical treatment. Even in these two patients (2 and 7, Table 2 ) stool nitrogen losses were unlikely to exceed 4 g/day (Buckell et al., 1977) . Patients were usually weighed daily and blood was taken for regular biochemical and haematological measurements; this included an anti-Factor X assay (Sigma Ltd.) in those given heparin, this being the best method available for measuring small amounts of the anticoagulant. Arm muscle bulk was measured in 10 patients by comparing triceps fat fold (estimated with calipers) and arm circumference (Gurney and Jelliffe, 1973) .
Intralipid-induced hyperlipidaemia has been reported to cause abnormalities of pulmonary diffusion in adults (Greene, Haslett and Demaree, 1976) and lung damage in premature babies (Levine, Wigglesworth and Desai, 1980) . Other workers have not found this (Wilmore, Moyland and Helmkamp, 1973) , but as large or aggregated fat particles in the emulsion mixture might, in theory, block pulmonary capillaries, single breath carbon monoxide transfer factor analyses were made. Blockage of pulmonary capillaries would lead to decrease in alveolar capillary blood volume and thus pulmonary diffusing capacity. Transfer factor is a measure of pulmonary diffusion capacity. The single breath technique requires little patient compliance and seemed most appropriate for these patients. The measurements were performed during and before or after treatment, whenever patients were well enough to travel to the lung function laboratory. A Transfer Test Model B instrument with valve box (Morgan Ltd.) was used and a correction was made for changes in haemoglobin concentration (Cotes, 1975) .
The project was approved by the North Nottingham District Hospitals Ethical Committee.
Results
Twenty patients (12 of whom had inflammatory bowel disease with complications requiring surgery) ( Table 2 ) received infusates of mixed nutrients for an average of 13-75 days each (range 8-23 days); in 10 of Feeds containing vitamins were stored at 4°C for no longer than 12 hr before commencement of infusion. Weekend feeds (without vitamins) were stored for no longer than 48 hr at 4°C. These procedures were based on the results of physiochemical studies reported elsewhere (Burnham et al.. 1983). these patients only peripheral veins were used (mean duration 12 days, range 8-18 days), the infusion site being changed every 24-48 hr. Positive nitrogen balance as measured in this study was maintained in all but one individual (M.H.) (Fig. 1) , although many were very ill (Table 2) . Even assuming the most severe stool nitrogen loss of 4 g/day, of those with acute inflammation studied before surgery only one other patient (D.P.) would have been in deficit. This in itself is unlikely, as he gained 4 kg in weight and increased his serum albumin from 14 g/litre to 21 g/litre during intravenous feeding. The mean arm muscle area (in the 10 patients measured), mean weight and mean serum albumin tended to increase during the period of intravenous feeding. The differences were not statistically significant; the study period was probably too short to show this (Table 3) . The weight and serum albumin measurements were subject to some distortion because initially oedematous patients lost weight during intravenous feeding and dehydrated patients showed a fall in serum albumin when this was corrected by infusion.
No patient showed clinical evidence of adverse effects, hyperglycaemia did not occur and serum triglyceride levels never rose above 2 mmol/litre. Transfer factor did not deteriorate as a consequence of the infusion in the 12 patients studied (Fig. 2) . Abnormal liver function tests developed in 9 patients during feeding, changes consisting of an elevated alkaline phosphatase (5 patients), and glutamyl transpeptidase (8 patients), serum glutamate pyruvate transferase (3 patients) and serum bilirubin (2 patients). In no case was it necessary to discontinue intravenous feeding, and all tests returned to normal after intravenous feeding had ceased. Some 'creaming' of the emulsion (Burnham et al., 1983) in the 3 litre bag was seen after the infusion had been running for [16] [17] [18] hr, but was easily reversed by gentle squeezing of the bag and did not recur in the remaining 6-8 hr. Heparin activity in plasma never exceeded 0.03 U/ml in those who received this agent. No patient developed deep vein thrombosis, pulmonary embolism or bleeding problems during surgery while feeds containing heparin were being infused. Five patients did develop mild phlebitis at the drip site, but this was rarely a difficulty provided the cannula was resited regularly in a large arm vein, and drugs likely to cause phlebitis were not given by the same route. The problem of hyperglycaemia seen with dextrose based solutions is also avoided, even in those patients whose poor peripheral veins mean a central line must be used for long-term feeding.
Despite the simplicity of the method, adequate nutritional support can be provided for ill patients. Within the limits of the mixtures tested, the intake of energy, nitrogen and electrolytes can be adjusted to the needs of each patient. Clearly, further studies are required to define other mixtures which may be safely used. However, our results agree with clinical studies performed in France (Solassol and Joyeux, 1974) , where an Intralipid-based feeding mixture has been used successfully for some years. There is evidence that a combination of fat and carbohydrate calories is to be preferred as an energy source in intravenous nutrition (Lee, 1977; Askanazi et al., 1980; Macfie, Smith and Hill, 1981; Kirkpatrick, Dahn and Lewis, 1981) .
Creaming of the emulsion during infusion, presumably due to the presence of aggregated particles, was easily reversed by gentle shaking. This did not recur during the infusion and did not pose a clinical or pharmaceutical problem.
Abnormal liver function tests were noted in 9 of the patients. However, this is a recognised complication of intravenous and nasogastric tube feeding (Tweedle et al., 1979) (Burnham et al., 1983) . Further experience with this method of intravenous feeding confirms the clinical benefit reported in this paper. We are now examining other amino acid solutions to assess their suitability for mixing with Intralipid. 
